Accendra Health (NYSE:ACH) Upgraded at Zacks Research

Zacks Research upgraded shares of Accendra Health (NYSE:ACH) from a strong sell rating to a hold rating in a research note issued to investors on Tuesday morning,Zacks.com reports.

Separately, Weiss Ratings initiated coverage on Accendra Health in a report on Wednesday, April 8th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Reduce”.

Accendra Health Price Performance

Accendra Health stock opened at $3.34 on Tuesday. The firm has a market capitalization of $255.31 million, a PE ratio of 3.64, a P/E/G ratio of 2.82 and a beta of 1.27. Accendra Health has a one year low of $1.84 and a one year high of $9.55.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.